Ajanta Pharma has informed that the exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 14,2021 for Ravi Agrawal, Trustee Ravi Agrawal Trust.
The above information is a part of company’s filings submitted to BSE.